TY - JOUR
T1 - A case report of septic shock syndrome caused by S. pneumoniae in an immunocompromised patient despite of vaccination
AU - Singer, Josef
AU - Testori, Christoph
AU - Schellongowski, Peter
AU - Handisurya, Ammon
AU - Müller, Catharina
AU - Reitter, Eva Maria
AU - Graninger, Wolfgang
AU - Knöbl, Paul
AU - Staudinger, Thomas
AU - Winkler, Stefan
AU - Thalhammer, Florian
N1 - Publisher Copyright:
© 2017 The Author(s).
PY - 2017/6/22
Y1 - 2017/6/22
N2 - Background and case presentation: We report a case of septic shock syndrome caused by Streptococcus pneumoniae in a patient who had undergone splenectomy due to an autoimmune lymphoproliferative syndrome (ALPS), which is characterized as a dysfunction of immunoregulation. Although the patient was vaccinated with a conjugated polysaccharide vaccine after the splenectomy, he was still susceptible to S. pneumoniae infection, because the isolated serovar (24F), a serovar long thought to be apathogenic, is not covered by any vaccine currently approved, neither a conjugated nor an unconjugated polysaccharide one. Conclusions: This case demonstrates that, due to presence of different serovars, also infections with bacteria against which patients are vaccinated have to be considered as differential diagnosis. Although vaccine development has extended the coverage of S. pneumoniae from 7 to 23 serovars within recent years, there is still demand for novel vaccines which can provide broader protection also against so-thought "apathogenic" strains, especially for groups at high risk.
AB - Background and case presentation: We report a case of septic shock syndrome caused by Streptococcus pneumoniae in a patient who had undergone splenectomy due to an autoimmune lymphoproliferative syndrome (ALPS), which is characterized as a dysfunction of immunoregulation. Although the patient was vaccinated with a conjugated polysaccharide vaccine after the splenectomy, he was still susceptible to S. pneumoniae infection, because the isolated serovar (24F), a serovar long thought to be apathogenic, is not covered by any vaccine currently approved, neither a conjugated nor an unconjugated polysaccharide one. Conclusions: This case demonstrates that, due to presence of different serovars, also infections with bacteria against which patients are vaccinated have to be considered as differential diagnosis. Although vaccine development has extended the coverage of S. pneumoniae from 7 to 23 serovars within recent years, there is still demand for novel vaccines which can provide broader protection also against so-thought "apathogenic" strains, especially for groups at high risk.
KW - Autoimmune lymphoproliferative syndrome (ALPS)
KW - Case report
KW - Overwhelming post-splenectomy infection (OPSI)
KW - Streptococcus pneumoniae Serovar 24F
KW - Vaccination
KW - Vaccines, Conjugate/pharmacology
KW - Humans
KW - Serogroup
KW - Male
KW - Streptococcus pneumoniae/immunology
KW - Splenectomy
KW - Pneumococcal Infections/complications
KW - Autoimmune Lymphoproliferative Syndrome/surgery
KW - Treatment Failure
KW - Adult
KW - Pneumococcal Vaccines/pharmacology
KW - Immunocompromised Host
KW - Shock, Septic/drug therapy
UR - http://www.scopus.com/inward/record.url?scp=85021225331&partnerID=8YFLogxK
U2 - 10.1186/s12879-017-2481-y
DO - 10.1186/s12879-017-2481-y
M3 - Case report
C2 - 28641577
AN - SCOPUS:85021225331
SN - 1471-2334
VL - 17
JO - BMC Infectious Diseases
JF - BMC Infectious Diseases
IS - 1
M1 - 442
ER -